We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLBK
3201
DELISTED
Old Line Bancshares, Inc.
OLBK
-36,688
Closed -$1.06M
AVDR
3202
DELISTED
Avedro, Inc Common Stock
AVDR
-16,346
Closed -$372K
MCRN
3203
DELISTED
Milacron Holdings Corp.
MCRN
-666,156
Closed -$11.1M
DOVA
3204
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
-53,310
Closed -$1.49M
DF
3205
DELISTED
Dean Foods Company
DF
-217,479
Closed -$253K
GHDX
3206
DELISTED
Genomic Health, Inc.
GHDX
-149,696
Closed -$10.2M
LTXB
3207
DELISTED
LegacyTexas Financial Group Inc
LTXB
-337,733
Closed -$14.7M
NRCG
3208
DELISTED
NRC Group Holdings Corp.
NRCG
-28,595
Closed -$356K
UBNK
3209
DELISTED
United Financial Bancorp, Inc.
UBNK
-304,445
Closed -$4.15M
CJ
3210
DELISTED
C&J Energy Services, Inc.
CJ
-398,450
Closed -$4.28M
CVRS
3211
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
-718,138
Closed -$3.07M
MDSO
3212
DELISTED
Medidata Solutions, Inc.
MDSO
-397,963
Closed -$36.4M
RTEC
3213
DELISTED
Rudolph Technologies Inc
RTEC
-187,296
Closed -$4.94M
ALDR
3214
DELISTED
Alder Biopharmaceuticals
ALDR
-426,698
Closed -$8.05M
ISCA
3215
DELISTED
International Speedway Corp
ISCA
-208,461
Closed -$9.38M
NCI
3216
DELISTED
Navigant Consulting, Inc.
NCI
-390,527
Closed -$10.9M
TYPE
3217
DELISTED
Monotype Imaging Holdings Inc.
TYPE
-246,433
Closed -$4.88M
CTWS
3218
DELISTED
Connecticut Water Service Inc
CTWS
-72,542
Closed -$5.08M
ROX
3219
DELISTED
Castle Brands, Inc.
ROX
-56,154
Closed -$71K
CBLK
3220
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-307,483
Closed -$7.99M
VSM
3221
DELISTED
Versum Materials, Inc.
VSM
-736,181
Closed -$39M
BID
3222
DELISTED
Sotheby's
BID
-333,793
Closed -$19M
NYNY
3223
DELISTED
Empire Resorts, Inc.
NYNY
-24,993
Closed -$241K
BAS
3224
DELISTED
Basis Energy Services, Inc.
BAS
-934,336
Closed -$1.35M
CELG
3225
DELISTED
Celgene Corp
CELG
-3,248,946
Closed -$323M

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.